Cargando…
Assessment of the Chemosensitizing Activity of TAT-RasGAP(317-326) in Childhood Cancers
Although current anti-cancer protocols are reasonably effective, treatment-associated long-term side effects, induced by lack of specificity of the anti-cancer procedures, remain a challenging problem in pediatric oncology. TAT-RasGAP(317-326) is a RasGAP-derived cell-permeable peptide that acts as...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4380404/ https://www.ncbi.nlm.nih.gov/pubmed/25826368 http://dx.doi.org/10.1371/journal.pone.0120487 |